Published in Wound Repair Regen on April 29, 2015
Intracellular Cleavage of the Cx43 C-Terminal Domain by Matrix-Metalloproteases: A Novel Contributor to Inflammation? Mediators Inflamm (2015) 0.85
Gap junctions and cancer: communicating for 50 years. Nat Rev Cancer (2016) 0.83
Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases. Pharmacol Res (2015) 0.79
The Role of Connexins in Wound Healing and Repair: Novel Therapeutic Approaches. Front Physiol (2016) 0.76
Kinase programs spatiotemporally regulate gap junction assembly and disassembly: Effects on wound repair. Semin Cell Dev Biol (2015) 0.76
Diabetes Increases Cryoinjury Size with Associated Effects on Cx43 Gap Junction Function and Phosphorylation in the Mouse Heart. J Diabetes Res (2015) 0.76
Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization. Br J Pharmacol (2016) 0.75
Connexin-Based Therapeutics and Tissue Engineering Approaches to the Amelioration of Chronic Pancreatitis and Type I Diabetes: Construction and Characterization of a Novel Prevascularized Bioartificial Pancreas. J Diabetes Res (2015) 0.75
Bridging the gap to therapeutic strategies based on connexin/pannexin biology. J Transl Med (2016) 0.75
Connexins, Pannexins, and Their Channels in Fibroproliferative Diseases. J Membr Biol (2016) 0.75
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications. Pharmacol Rev (2017) 0.75
Connexin channel and its role in diabetic retinopathy. Prog Retin Eye Res (2017) 0.75
Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg (2007) 2.90
Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol Biol Cell (2005) 2.62
Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care (1998) 2.09
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care (2003) 2.09
Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care (2001) 1.97
Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol Biol Cell (2011) 1.81
Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg (2004) 1.68
Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care (2003) 1.68
Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. Ann Intern Med (2013) 1.62
Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Invest Dermatol (2004) 1.61
Mutations in connexin genes and disease. Eur J Clin Invest (2010) 1.56
Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev (2004) 1.54
A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev (2008) 1.53
The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen (2004) 1.48
Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol (2003) 1.48
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. Diabetes Care (1999) 1.44
Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care (2002) 1.42
Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol (2008) 1.38
Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci (2006) 1.36
Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care (2004) 1.32
A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury. Circ Res (2011) 1.29
Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes (2012) 1.21
Abnormal connexin expression underlies delayed wound healing in diabetic skin. Diabetes (2007) 1.20
Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci (2010) 1.12
Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int (2003) 1.11
Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding. Regen Med (2009) 1.09
A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev (2012) 1.08
The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J (2008) 1.08
Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem Biophys Res Commun (2006) 0.99
Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med (2011) 0.97
NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial. Wound Repair Regen (2012) 0.93
Expression and function of connexins in the epidermis, analyzed with transgenic mouse mutants. Eur J Cell Biol (2004) 0.92
Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration. Cell Biol Int (2012) 0.91
The unstoppable connexin43 carboxyl-terminus: new roles in gap junction organization and wound healing. Ann N Y Acad Sci (2006) 0.89
Cell-to-cell communication and expression of gap junctional proteins in human diabetic and nondiabetic skin fibroblasts: effects of basic fibroblast growth factor. Endocrine (1999) 0.86
AMPK-mediated downregulation of connexin43 and premature senescence of mesangial cells under high-glucose conditions. Exp Gerontol (2014) 0.84